Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 2 Histology of dysplastic lesions

From: Discrimination of cirrhotic nodules, dysplastic lesions and hepatocellular carcinoma by their vibrational signature

Patient Nodule size (cm) Associated HCC Portal tracts 0/1 Unpaired arteries 0/1/2 Cell density Trabeculae thickness Pseudo-glands 0/1 Steatosis (%) Large cell dysplasia Small cell dysplasia Stromal invasion 0/1 Nodule in the nodule CD34 (%) Glypican3 (%) Glutamine synthetase (%) HSP70 (%) Pathological diagnosis
33 2.4 Yes 1 2 X4 >3 1 5 0 1 1 HCC nodules 80 40 25 15 HGDN with HCC nodules
34 2.4 No 1 1 X1.5 2 0 0 0 1 0 0 70 10 70 0 HGDN
35 2.7 Yes 1 0/1 X2 2–3 1 10 0 1 1 0 10 0 15 5 early HCC
36 3.4 No 1 1 X2 2–3 1 25 0 1 0 0 10 10 0 (zonal) 0 HGDN
37 2 Yes 0 0/1 X1.5 2–3 0 0 0 1 0 0 0 5 0 (zonal) 0 HGDN
38 1 Yes 1 0 X1.5 2 0 0 0 0 0 0 40 0 0 (zonal) 0 LGDN
39 1.1 Yes rares 1 X2 focally > 3 1 0 0 1 0 0 30 0 0 (zonal) 0 HGDN
  1. HCC hepatocellular carcinoma, LGDN low grade dysplastic nodule, HGDN high grade dysplastic nodule